PI3K/AKT signaling has been reported to play an essential role in the proliferation and survival of enzalutamide-resistant PCa cells [9], we therefore investigated if treatment with GRT can inhibit the proliferation and survival of enzalutamide-resistant PCa cells. Here, AKT1 is linked to posterior cortical atrophy.